Generics in the Netherlands
Description
Generics in the Netherlands
Summary
Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The Dutch generics market recorded revenues of $3.0 billion in 2024, representing a compound annual growth rate (CAGR) of 3.3% between 2019 and 2024.
- Market consumption volume increased with a CAGR of 0.5% between 2019 and 2024, reaching a total of 79.4 % of total pharma volume in 2024.
- In 2024, the revenue of the Dutch generics market experienced an annual growth of 4.3%. The market’s growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in the Netherlands
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the Netherlands
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands generics market with five year forecasts
- What was the size of the Netherlands generics market by value in 2024?
- What will be the size of the Netherlands generics market in 2029?
- What factors are affecting the strength of competition in the Netherlands generics market?
- How has the market performed over the last five years?
- Who are the top competitors in the Netherlands's generics market?
Table of Contents
44 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the strategies of the leading players?
- 8 Company Profiles
- 8.1. Sandoz Group AG
- 8.2. Teva Pharmaceutical Industries Ltd
- 8.3. Viatris Inc
- 8.4. Sanofi
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Netherlands generics market value: $ million, 2019-24
- Table 2: Netherlands generics market volume: % of total pharma volume, 2019-24
- Table 3: Netherlands generics market geography segmentation: $ million, 2024
- Table 4: Netherlands generics market value forecast: $ million, 2024-29
- Table 5: Netherlands generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Sandoz Group AG: Key Facts
- Table 7: Sandoz Group AG: Annual Financial Ratios
- Table 8: Sandoz Group AG: Key Employees
- Table 9: Teva Pharmaceutical Industries Ltd: Key Facts
- Table 10: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 11: Teva Pharmaceutical Industries Ltd: Key Employees
- Table 12: Viatris Inc: Key Facts
- Table 13: Viatris Inc: Annual Financial Ratios
- Table 14: Viatris Inc: Key Employees
- Table 15: Sanofi: Key Facts
- Table 16: Sanofi: Annual Financial Ratios
- Table 17: Sanofi: Key Employees
- Table 18: Sanofi: Key Employees Continued
- Table 19: Netherlands Size of Population (Million), 2020-24
- Table 20: Netherlands Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 21: Netherlands GDP (Current Prices, $ Billion), 2020-24
- Table 22: Netherlands Inflation, 2020-24
- Table 23: Netherlands Consumer Price Index (Absolute), 2020-24
- Table 24: Netherlands Exchange Rate, 2019-24
- List of Figures
- Figure 1: Netherlands generics market value: $ million, 2019-24
- Figure 2: Netherlands generics market volume: % of total pharma volume, 2019-24
- Figure 3: Netherlands generics market geography segmentation: % share, by value, 2024
- Figure 4: Netherlands generics market value forecast: $ million, 2024-29
- Figure 5: Netherlands generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in the Netherlands, 2024
- Figure 7: Drivers of buyer power in the generics market in the Netherlands, 2024
- Figure 8: Drivers of supplier power in the generics market in the Netherlands, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in the Netherlands, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in the Netherlands, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in the Netherlands, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

